1
Researchers have found that a compound inhibits a group of proteins called BMP receptors. This compound, called cercosporamide, was previously only known to inhibit a different group of proteins. When overactive, BMP receptors can lead to several diseases. Studying compounds that may counteract this overactivity may lead to more treatment options in the future.